Chris is the CEO and co-founder of Galen Data, Inc., a configurable, scalable, FDA-Compliant software platform that enables connecting medical devices to a FDA-compliant cloud. He has over 25 years of experience developing sophisticated technology in the medical device industry including Cyberonics and the aerospace industry including NASA and Iridium. As a project manager and principal software engineer for a venture-funded FDA Class III medical device company, he was responsible for executing key software projects through a formal design control, verification, and validation process in compliance with FDA regulations. Chris DuPont also has been involved with numerous Class III medical startups in various roles and started the commercially successful Life Science Division at Tietronix Software, Inc. Chris DuPont has also co-authored and submitted seven U.S. patents covering patient management and threshold optimization software applications for implantable medical device systems (four patents issued to date). He has initiated and led the effort to achieve ISO 13485 certification, for two separate companies, which included building from scratch a compliant ISO 13485 (Medical Device – Quality Management System International Standard) and ISO 14971 Risk Management system. Chris DuPont has a Master’s degree in Electrical Engineering with a focus on intelligent software.